REG-BARCLAYS PLC FORM 8.3 - AON PLC Amendment
09/10/2020 08:15
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20201009:nBw2LqgrLa
FORM 8.3 - AON PLC Amendment
Ap19
FORM 8.3
Amendment to Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in AON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 06 October 2020
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
377,539 0.16% 2,591,011 1.12%
(2) Derivatives (other than options):
538,686 0.23% 28,200 0.01%
(3) Options and agreements to
purchase/sell: 106,599 0.05% 106,599 0.05%
TOTAL:
1,022,824 0.44% 2,725,810 1.18%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 2 205.8100 USD
Purchase 16 206.5100 USD
Purchase 34 205.9100 USD
Purchase 49 205.5338 USD
Purchase 65 206.4200 USD
Purchase 100 205.1100 USD
Purchase 100 205.4750 USD
Purchase 431 207.8700 USD
Purchase 600 205.9558 USD
Purchase 601 206.4608 USD
Purchase 2,411 206.0844 USD
Purchase 3,269 206.3195 USD
Purchase 3,540 207.7043 USD
Purchase 4,336 207.3872 USD
Purchase 8,364 205.6500 USD
Purchase 9,117 205.8419 USD
Purchase 21,744 207.2223 USD
Purchase 47,226 207.1761 USD
Sale 2 205.8100 USD
Sale 4 205.6450 USD
Sale 100 207.3500 USD
Sale 100 205.9000 USD
Sale 196 206.0412 USD
Sale 200 205.7050 USD
Sale 200 207.7850 USD
Sale 200 205.3575 USD
Sale 208 206.0078 USD
Sale 300 206.3133 USD
Sale 392 207.7224 USD
Sale 431 207.8700 USD
Sale 480 206.1314 USD
Sale 569 207.6623 USD
Sale 789 206.7172 USD
Sale 792 206.3032 USD
Sale 1,000 207.4745 USD
Sale 1,230 207.7844 USD
Sale 1,232 207.7766 USD
Sale 1,544 208.6457 USD
Sale 1,738 207.8670 USD
Sale 2,120 207.7109 USD
Sale 2,443 205.7670 USD
Sale 3,140 207.4434 USD
Sale 3,856 207.5435 USD
Sale 4,094 207.0296 USD
Sale 4,425 206.6281 USD
Sale 4,826 207.2058 USD
Sale 6,136 205.9289 USD
Sale 7,530 205.6500 USD
Sale 8,402 207.4891 USD
Sale 10,678 206.0334 USD
Sale 13,828 207.3628 USD
Sale 17,825 207.1474 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 9 Oct 2020
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -106,599 214.5780 European Oct 20, 2020
Put Options Written 106,599 214.5780 European Oct 20, 2020
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20201009005119/en/
(https://www.businesswire.com/news/home/20201009005119/en/)
BARCLAYS PLC
Copyright Business Wire 2020Recent news on Barclays
See all newsREG - Stock Exch Notice - Admission to Trading - 17/12/2025
AnnouncementREG - Barclays PLC - Additional Listing
AnnouncementREG - Barclays PLC - Transaction in Own Shares
AnnouncementREG - Barclays PLC - Director/PDMR Shareholding
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
Announcement